雅各臣科研制药(02633.HK)完成配售6,600万股净筹3,880万元

阿斯达克财经02-27

雅各臣科研制药(02633.HK) 公布，配售协议所载的所有条件经已达成，配售已于今日(27日)完成。配售代理已根据配售协议的条款及条件，按每股配售股份0.6元的配售价向不少于六名承配人成功配售合共6,600万股配售股份，占经发行配售股份扩大后已发行股本约3.3%。扣除配售佣金及其他相关开支后，配售所得款项净额预期将约3,880万元。公司拟动用该等所得款项净额，透过增强生产及包装流程自动化以扩大其...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2414840075?lang=zh_CN&edition=full","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20201020173713026_s.jpg","is_english":false,"pubTime":"2024-02-27 16:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2414840075","market":"us","top_or_hot":-1,"title":"雅各臣科研制药(02633.HK)完成配售6,600万股  净筹3,880万元","media":"阿斯达克财经","content":"<div>\n<p>雅各臣科研制药(02633.HK) 公布，配售协议所载的所有条件经已达成，配售已于今日(27日)完成。配售代理已根据配售协议的条款及条件，按每股配售股份0.6元的配售价向不少于六名承配人成功配售合共6,600万股配售股份，占经发行配售股份扩大后已发行股本约3.3%。扣除配售佣金及其他相关开支后，配售所得款项净额预期将约3,880万元。公司拟动用该等所得款项净额，透过增强生产及包装流程自动化以扩大其...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1329090/latest-news/AAFN\">网页链接</a>\n\n</div>\n","source":"aastocks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>雅各臣科研制药(02633.HK)完成配售6,600万股  净筹3,880万元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n雅各臣科研制药(02633.HK)完成配售6,600万股  净筹3,880万元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-27 16:38 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1329090/latest-news/AAFN><strong>阿斯达克财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>雅各臣科研制药(02633.HK) 公布，配售协议所载的所有条件经已达成，配售已于今日(27日)完成。配售代理已根据配售协议的条款及条件，按每股配售股份0.6元的配售价向不少于六名承配人成功配售合共6,600万股配售股份，占经发行配售股份扩大后已发行股本约3.3%。扣除配售佣金及其他相关开支后，配售所得款项净额预期将约3,880万元。公司拟动用该等所得款项净额，透过增强生产及包装流程自动化以扩大其...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1329090/latest-news/AAFN\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02633","symbol_name":"雅各臣科研制药","start_time":0,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1329090/latest-news/AAFN","article_id":"2414840075","we_media_id":null,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20201020173713026_s.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2414840075","pubTimestamp":1709023080,"sourceInfo":{"source_id":"aastocks_highlight","name":"阿思達克財經"},"weMediaInfo":null,"summary":"雅各臣科研制药(02633.HK) 公布，配售协议所载的所有条件经已达成，配售已于今日(27日)完成。配售代理已根据配售协议的条款及条件，按每股配售股份0.6元的配售价向不少于六名承配人成功配售合共6,600万股配售股份，占经发行配售股份扩大后已发行股本约3.3%。扣除配售佣金及其他相关开支后，配售所得款项净额预期将约3,880万元。公司拟动用该等所得款项净额，透过增强生产及包装流程自动化以扩大其生产能力。所得款项净额主要用作翻新集团生产设施以及购置机器及设备的开支。(sl/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02633":"雅各臣科研制药","BK1191":"制药"},"translate_title":"Jacobson Scientific Research Pharmaceutical (02633. HK) completed the placement of 66 million shares and raised a net of 38.8 million yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02633":1},"content_text":"雅各臣科研制药(02633.HK) 公布，配售协议所载的所有条件经已达成，配售已于今日(27日)完成。配售代理已根据配售协议的条款及条件，按每股配售股份0.6元的配售价向不少于六名承配人成功配售合共6,600万股配售股份，占经发行配售股份扩大后已发行股本约3.3%。扣除配售佣金及其他相关开支后，配售所得款项净额预期将约3,880万元。公司拟动用该等所得款项净额，透过增强生产及包装流程自动化以扩大其生产能力。所得款项净额主要用作翻新集团生产设施以及购置机器及设备的开支。(sl/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2414840075"}

雅各臣科研制药(02633.HK)完成配售6,600万股 净筹3,880万元

精彩评论

雅各臣科研制药(02633.HK)完成配售6,600万股净筹3,880万元